Trial ID or NCT#
To determine the safety of local palliative radiation therapy used in combination with anti-CTLA-4 immunotherapy.
A Pilot Study of Ipilimumab in Subjects With Stage IV Melanoma Receiving Palliative Radiation Therapy
Contact us to find out if this trial is right for you.
Chuck Di Bari